Lindner, T., Loktev, A., Altmann, A., Giesel, F. L., Kratochwil, C., Debus, J., . . . Haberkorn, U. (2018). Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. Journal of nuclear medicine, 59(9), . https://doi.org/10.2967/jnumed.118.210443
Chicago-Zitierstil (17. Ausg.)Lindner, Thomas, Anastasia Loktev, Annette Altmann, Frederik L. Giesel, Clemens Kratochwil, Jürgen Debus, Dirk Jäger, Walter Mier, und Uwe Haberkorn. "Development of Quinoline-based Theranostic Ligands for the Targeting of Fibroblast Activation Protein." Journal of Nuclear Medicine 59, no. 9 (2018). https://doi.org/10.2967/jnumed.118.210443.
MLA-Zitierstil (9. Ausg.)Lindner, Thomas, et al. "Development of Quinoline-based Theranostic Ligands for the Targeting of Fibroblast Activation Protein." Journal of Nuclear Medicine, vol. 59, no. 9, 2018, https://doi.org/10.2967/jnumed.118.210443.